Common Expression of Stemness Molecular Markers and Early Cardiac Transcription Factors in Human Wharton's Jelly-Derived Mesenchymal Stem Cells and Embryonic Stem Cells

2013 ◽  
Vol 22 (10) ◽  
pp. 1883-1900 ◽  
Author(s):  
Lian Ru Gao ◽  
Ning K. Zhang ◽  
Qing A. Ding ◽  
Hai Y. Chen ◽  
Xiang Hu ◽  
...  
2014 ◽  
Vol 67 (3) ◽  
pp. 493-505 ◽  
Author(s):  
Patcharee Prasajak ◽  
Piyaporn Rattananinsruang ◽  
Kamonnaree Chotinantakul ◽  
Chavaboon Dechsukhum ◽  
Wilairat Leeanansaksiri

2008 ◽  
Vol 20 (1) ◽  
pp. 221
Author(s):  
E. J. Kang ◽  
B. Mohana Kumar ◽  
H. J. Song ◽  
M. K. Kim ◽  
S. A. Ock ◽  
...  

Wharton's jelly derived from mesoderm of umbilical cord matrix is an abundant source of stem cells such as mesenchymal and more primitive stem cells that don't raise the ethical issues associated with embryonic stem cells. The Oct-4 POU transcription factor, Nanog, and Sox-2 are expressed in embryonic stem cells and have been implicated in embryonic development and maintenance of pluripotency. The present study examined the expression of early transcription factors, Oct-4, Nanog, and Sox-2, and capability of differentiation to osteocytes, adipocytes, and chondrocytes of the cells of Wharton's jelly isolated from porcine umbilical cord. Wharton's jelly was obtained from the umbilical cord of post-natal piglets (immediately after birth). This tissue was diced into 2-mm-diameter explants and attached to tissue culture dishes. Cells were then cultured in DMEM/F12 supplemented with 10% fetal blood serum (FBS), 10 ng mL–1 basic fibroblast growth factor (bFGF), 1 nm dexamethasone, and 10 nm insulin at 38.5�C, 5% CO2 in air. Expression of Oct-4, Nanog, and Sox-2 by these cells was analyzed by immunocytochemistry and RT-polymerase chain reaction (PCR), and compared with expression by porcine bone marrow MSCs established in our laboratory. Osteogenic, adipogenic, and chondrogenic differentiation were induced following the protocols described earlier (Jin et al. 2007 Int. J. Dev. Biol. 51, 85–90; Mohana Kumar et al. 2007 Mol. Cells, in press). Cells isolated from Wharton's jelly expressed Oct-4, Nanog, and Sox-2 especially in colonies/clusters, as observed by immunocytochemistry and gene expression by RT-PCR, and this expression was higher than by MSCs isolated from bone marrow. Osteocytes were documented by the formation of the mineral nodules with alkaline phosphatase-positive cells and deposition of calcium. Differentiation into adipocytes was exhibited by oil red O staining of lipid vacuoles. Alcian blue staining for proteoglycans demonstrated the differentiation of chondrogenic cells. In conclusion, the results of the present study suggest that cells isolated from Wharton's jelly have properties of primitive pluripotency and multilineage differentiation. These stem cells, therefore, can serve as an easily accessible and expandable source possessing potential for preclinical applications using a large animal model. This work was supported by Grant No. 20070301034040 from Bio-organ, Republic of Korea.


2020 ◽  
Vol 9 (4) ◽  
pp. 1102 ◽  
Author(s):  
Katarzyna Stefańska ◽  
Katarzyna Ożegowska ◽  
Greg Hutchings ◽  
Małgorzata Popis ◽  
Lisa Moncrieff ◽  
...  

Stem cell therapies offer a great promise for regenerative and reconstructive medicine, due to their self-renewal and differentiation capacity. Although embryonic stem cells are pluripotent, their utilization involves embryo destruction and is ethically controversial. Therefore, adult tissues that have emerged as an alternative source of stem cells and perinatal tissues, such as the umbilical cord, appear to be particularly attractive. Wharton’s jelly, a gelatinous connective tissue contained in the umbilical cord, is abundant in mesenchymal stem cells (MSCs) that express CD105, CD73, CD90, Oct-4, Sox-2, and Nanog among others, and have the ability to differentiate into osteogenic, adipogenic, chondrogenic, and other lineages. Moreover, Wharton’s jelly-derived MSCs (WJ-MSCs) do not express MHC-II and exhibit immunomodulatory properties, which makes them a good alternative for allogeneic and xenogeneic transplantations in cellular therapies. Therefore, umbilical cord, especially Wharton’s jelly, is a promising source of mesenchymal stem cells.


Author(s):  
Malgorzata Witkowska-Zimny ◽  
Edyta Wrobel

AbstractRecently, stem cell biology has become an interesting topic, especially in the context of treating diseases and injuries using transplantation therapy. Several varieties of human stem cells have been isolated and identified in vivo and in vitro. Ideally, stem cells for regenerative medical application should be found in abundant quantities, harvestable in a minimally invasive procedure, then safely and effectively transplanted to either an autologous or allogenic host. The two main groups of stem cells, embryonic stem cells and adult stem cells, have been expanded to include perinatal stem cells. Mesenchymal stem cells from perinatal tissue may be particularly useful in the clinic for autologous transplantation for fetuses and newborns, and after banking in later stages of life, as well as for in utero transplantation in case of genetic disorders.This review highlights the characteristics and therapeutic potential of three human mesenchymal stem cell types obtained from perinatal sources: Wharton’s jelly, the amnion, and the chorion.


2012 ◽  
Vol 24 (2) ◽  
pp. 235-246 ◽  
Author(s):  
Kalamegam Gauthaman ◽  
Chui-Yee Fong ◽  
Cheyyatraivendran-Arularasu Suganya ◽  
Arjunan Subramanian ◽  
Arijit Biswas ◽  
...  

2018 ◽  
Vol 45 (5) ◽  
pp. 1001-1011 ◽  
Author(s):  
Rasha Noureldin M. Saleh ◽  
Daniel Dilg ◽  
Abla A. Abou Zeid ◽  
Doaa I. Hashad ◽  
Peter J. Scambler ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document